We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Therapeutic Processes and Treatment Outcome in Adolescents With Anxiety Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00071630
Recruitment Status : Completed
First Posted : October 30, 2003
Last Update Posted : November 7, 2013
National Institute of Mental Health (NIMH)
Information provided by:
Temple University

Brief Summary:
The purpose of this study is to examine the relationship between different aspects of cognitive behavior therapy (CBT) and treatment outcome.

Condition or disease Intervention/treatment Phase
Anxiety Disorders Behavioral: Cognitive Behavioral Therapy Phase 4

Detailed Description:

Anxiety disorders are common among children; if untreated, they can negatively affect children's lives. Evidence suggests that CBT can benefit children with anxiety disorders, but the causal mechanisms between therapy and beneficial outcomes have not been thoroughly investigated.

Audio and videotaped sessions of children currently receiving CBT and those who received CBT in previous trials will be examined. Various rating scales will be used to rate therapeutic alliance, child involvement, and therapist flexibility for each session of CBT. To evaluate potential process variables that contribute to participant drop-out, this study will compare the early process variables for children who complete treatment and for those who discontinue treatment.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 130 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Process as a Predictor of Outcomes in CBT for Youth
Study Start Date : September 2002
Estimated Study Completion Date : August 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety
U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   8 Years to 13 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion criteria:

  • Diagnosis of separation anxiety disorder, generalized anxiety disorder, or social phobia
  • At least one English-speaking parent

Exclusion criteria:

  • IQ < 80
  • Psychotic symptoms

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00071630

United States, Pennsylvania
Temple University
Philadelphia, Pennsylvania, United States, 19122
Australia, New South Wales
Macquarie University
Sydney, New South Wales, Australia, 2109
Sponsors and Collaborators
Temple University
National Institute of Mental Health (NIMH)

Additional Information:
ClinicalTrials.gov Identifier: NCT00071630     History of Changes
Other Study ID Numbers: R01MH064484 ( U.S. NIH Grant/Contract )
First Posted: October 30, 2003    Key Record Dates
Last Update Posted: November 7, 2013
Last Verified: September 2008

Keywords provided by Temple University:

Additional relevant MeSH terms:
Anxiety Disorders
Mental Disorders